• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

染料木黄酮暴露通过超高效液相色谱-串联质谱法干扰塞来昔布在SD雄性大鼠体内的药代动力学。

Genistein Exposure Interferes with Pharmacokinetics of Celecoxib in SD Male Rats by UPLC-MS/MS.

作者信息

Zheng Xiang, Wen Jian, Liu Teng-Hui, Ou-Yang Qiu-Geng, Cai Jian-Ping, Zhou Hong-Yu

机构信息

School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, Zhejiang, China.

出版信息

Biochem Res Int. 2017;2017:6510232. doi: 10.1155/2017/6510232. Epub 2017 Dec 4.

DOI:10.1155/2017/6510232
PMID:29387488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5745716/
Abstract

OBJECTIVE

To discuss the effects of genistein on the metabolism of celecoxib in vitro and in vivo.

METHOD

In vitro, the effects of genistein on the metabolism of celecoxib were studied using rat and human liver microsomes. In vivo, pharmacokinetics of celecoxib was evaluated in rats with or without genistein. Fifteen Sprague-Dawley (SD) rats were randomized into three groups: celecoxib (A group), celecoxib and 50 mg/kg genistein (B group), and celecoxib and 100 mg/kg genistein (C group). Single dose of 33.3 mg/kg celecoxib was orally administered 30 min after genistein ig. At 0.5, 1, 2, 3, 4, 6, 8, 10, 12, and 24 h after celecoxib administration, 300-400 µl blood samples were collected and the concentration of celecoxib was analyzed by ultrahigh-performance liquid chromatography-tandem mass spectrometry system.

RESULT

Genistein showed notable inhibitory effects on three microsomes. It affected pharmacokinetics of celecoxib in vivo experiments. Genistein had dramatically ability to suppress CYP2C9∗1 and ∗3. After pretreatment with genistein, AUC and of the C group were higher than B group. CL/F of C group was lower than the B group.

CONCLUSION

Genistein inhibits the conversion of celecoxib in vitro and in vivo. So, the dosage of celecoxib should be adjusted if it was used associated with genistein.

摘要

目的

探讨染料木黄酮对塞来昔布体内外代谢的影响。

方法

体外实验中,采用大鼠和人肝微粒体研究染料木黄酮对塞来昔布代谢的影响。体内实验中,对给予或未给予染料木黄酮的大鼠进行塞来昔布的药代动力学评估。将15只Sprague-Dawley(SD)大鼠随机分为三组:塞来昔布组(A组)、塞来昔布+50mg/kg染料木黄酮组(B组)和塞来昔布+100mg/kg染料木黄酮组(C组)。在染料木黄酮灌胃30分钟后,口服单剂量33.3mg/kg塞来昔布。在给予塞来昔布后0.5、1、2、3、4、6、8、10、12和24小时,采集300 - 400μl血样,采用超高效液相色谱-串联质谱系统分析塞来昔布浓度。

结果

染料木黄酮对三种微粒体均有显著抑制作用。在体内实验中,其影响了塞来昔布的药代动力学。染料木黄酮具有显著抑制CYP2C9∗1和∗3的能力。经染料木黄酮预处理后,C组的AUC和 高于B组。C组的CL/F低于B组。

结论

染料木黄酮在体内外均抑制塞来昔布的转化。因此,塞来昔布与染料木黄酮联用时,应调整其剂量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a55/5745716/9fd45358a3ef/BRI2017-6510232.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a55/5745716/9eacbb833b87/BRI2017-6510232.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a55/5745716/24fbefd5fa65/BRI2017-6510232.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a55/5745716/028a28f88c30/BRI2017-6510232.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a55/5745716/82c50e616e42/BRI2017-6510232.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a55/5745716/9fd45358a3ef/BRI2017-6510232.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a55/5745716/9eacbb833b87/BRI2017-6510232.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a55/5745716/24fbefd5fa65/BRI2017-6510232.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a55/5745716/028a28f88c30/BRI2017-6510232.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a55/5745716/82c50e616e42/BRI2017-6510232.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a55/5745716/9fd45358a3ef/BRI2017-6510232.005.jpg

相似文献

1
Genistein Exposure Interferes with Pharmacokinetics of Celecoxib in SD Male Rats by UPLC-MS/MS.染料木黄酮暴露通过超高效液相色谱-串联质谱法干扰塞来昔布在SD雄性大鼠体内的药代动力学。
Biochem Res Int. 2017;2017:6510232. doi: 10.1155/2017/6510232. Epub 2017 Dec 4.
2
Inhibitory effect of celecoxib on agomelatine metabolism in vitro and in vivo.塞来昔布对阿戈美拉汀体内外代谢的抑制作用。
Drug Des Devel Ther. 2018 Mar 9;12:513-519. doi: 10.2147/DDDT.S160316. eCollection 2018.
3
In vivo and in vitro metabolism and pharmacokinetics of cholinesterase inhibitor deoxyvasicine from aerial parts of Peganum harmala Linn in rats via UPLC-ESI-QTOF-MS and UPLC-ESI-MS/MS.通过 UPLC-ESI-QTOF-MS 和 UPLC-ESI-MS/MS 研究骆驼蓬地上部分胆碱酯酶抑制剂脱氧野尻霉素在大鼠体内和体外的代谢和药代动力学。
J Ethnopharmacol. 2019 May 23;236:288-301. doi: 10.1016/j.jep.2019.03.020. Epub 2019 Mar 11.
4
Quantitation of celecoxib and four of its metabolites in rat blood by UPLC-MS/MS clarifies their blood distribution patterns and provides more accurate pharmacokinetics profiles.采用超高效液相色谱-串联质谱法(UPLC-MS/MS)对大鼠血液中塞来昔布及其四种代谢产物进行定量分析,明确了它们的血液分布模式,并提供了更准确的药代动力学特征。
J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Sep 15;1001:202-11. doi: 10.1016/j.jchromb.2015.07.026. Epub 2015 Jul 19.
5
Evaluation of the Effects of Apatinib on the Pharmacokinetics of Venlafaxine and O-desmethylvenlafaxine in SD Male Rats by UPLC-MS/MS.UPLC-MS/MS 法评价阿帕替尼对 SD 雄性大鼠体内文拉法辛及其 O-去甲基代谢物药代动力学的影响。
Basic Clin Pharmacol Toxicol. 2018 Dec;123(6):721-726. doi: 10.1111/bcpt.13081. Epub 2018 Aug 2.
6
Inhibitory effect of resveratrol on the pharmacokinetic of ibrutinib by UPLC-MS/MS.UPLC-MS/MS 法研究白藜芦醇对伊布替尼药代动力学的影响。
Drug Dev Ind Pharm. 2019 Jan;45(1):27-31. doi: 10.1080/03639045.2018.1514044.
7
Pharmacokinetics interaction between imatinib and genistein in rats.伊马替尼与染料木黄酮在大鼠体内的药代动力学相互作用。
Biomed Res Int. 2015;2015:368976. doi: 10.1155/2015/368976. Epub 2015 Jan 5.
8
Effects of Dexmedetomidine on the Pharmacokinetics of Parecoxib and Its Metabolite Valdecoxib in Beagles by UPLC-MS/MS.UPLC-MS/MS 法研究右美托咪定对犬体内帕瑞昔布及其代谢物伐地昔布药代动力学的影响。
Biomed Res Int. 2020 Aug 6;2020:1563874. doi: 10.1155/2020/1563874. eCollection 2020.
9
A UPLC-MS/MS method for in vivo and in vitro pharmacokinetic studies of psoralenoside, isopsoralenoside, psoralen and isopsoralen from Psoralea corylifolia extract.UPLC-MS/MS 法用于研究补骨脂提取物中补骨脂素、异补骨脂素、补骨脂酚和异补骨脂酚的体内和体外药代动力学。
J Ethnopharmacol. 2014;151(1):609-17. doi: 10.1016/j.jep.2013.11.013. Epub 2013 Dec 4.
10
[UPLC-MS/MS determination of tanshinone ⅡA, salvianolic acid B and ginsenoside Rg₁ in Fufang Danshen preparation in rat plasma and brain tissues].超高效液相色谱-串联质谱法测定复方丹参制剂中丹参酮ⅡA、丹酚酸B和人参皂苷Rg₁在大鼠血浆和脑组织中的含量
Zhongguo Zhong Yao Za Zhi. 2017 Feb;42(3):580-586. doi: 10.19540/j.cnki.cjcmm.2017.0014.

引用本文的文献

1
Effect of extract and Andrographolide on the pharmacokinetics of Aceclofenac and Celecoxib in rats.提取物和穿心莲内酯对大鼠体内醋氯芬酸和塞来昔布药代动力学的影响。
Futur J Pharm Sci. 2023;9(1):1. doi: 10.1186/s43094-022-00450-4. Epub 2023 Jan 3.
2
Isoflavones in Soybean as a Daily Nutrient: The Mechanisms of Action and How They Alter the Pharmacokinetics of Drugs.大豆中的异黄酮作为日常营养素:作用机制及其如何改变药物的药代动力学。
Turk J Pharm Sci. 2021 Dec 31;18(6):799-810. doi: 10.4274/tjps.galenos.2020.79106.
3
Structural Modification of Nanomicelles through Phosphatidylcholine: The Enhanced Drug-Loading Capacity and Anticancer Activity of Celecoxib-Casein Nanoparticles for the Intravenous Delivery of Celecoxib.

本文引用的文献

1
Inflammation and depression: a causal or coincidental link to the pathophysiology?炎症与抑郁:是病理生理学上的因果关联还是巧合?
Acta Neuropsychiatr. 2018 Feb;30(1):1-16. doi: 10.1017/neu.2016.69. Epub 2017 Jan 23.
2
Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of celecoxib and its carboxylic acid metabolite.CYP2C9基因多态性对塞来昔布及其羧酸代谢产物药代动力学的影响。
Arch Pharm Res. 2017 Mar;40(3):382-390. doi: 10.1007/s12272-016-0861-2. Epub 2016 Nov 18.
3
Hepatotoxicity induced by coxibs: how concerned should we be?
通过磷脂酰胆碱对纳米胶束进行结构修饰:塞来昔布-酪蛋白纳米颗粒用于塞来昔布静脉给药时增强的载药能力和抗癌活性
Nanomaterials (Basel). 2020 Mar 2;10(3):451. doi: 10.3390/nano10030451.
昔布类药物引起的肝毒性:我们应多担心?
Expert Opin Drug Saf. 2016 Nov;15(11):1463-1475. doi: 10.1080/14740338.2016.1225719. Epub 2016 Aug 26.
4
Interaction of isoflavonoids with human liver microsomal cytochromes P450: inhibition of CYP enzyme activities.异黄酮与人类肝脏微粒体细胞色素P450的相互作用:对CYP酶活性的抑制作用
Xenobiotica. 2017 Apr;47(4):324-331. doi: 10.1080/00498254.2016.1195028. Epub 2016 Jun 17.
5
Effects of CYP2C19 variants on methadone metabolism in vitro.CYP2C19基因变异体对美沙酮体外代谢的影响。
Drug Test Anal. 2017 Apr;9(4):634-639. doi: 10.1002/dta.1997. Epub 2016 May 19.
6
Celecoxib for the treatment of atherosclerosis.塞来昔布用于治疗动脉粥样硬化。
Expert Opin Investig Drugs. 2016;25(5):619-33. doi: 10.1517/13543784.2016.1161756. Epub 2016 Mar 21.
7
A Randomized, Placebo-Controlled, Phase II, Presurgical Biomarker Trial of Celecoxib Versus Exemestane in Postmenopausal Breast Cancer Patients.随机、安慰剂对照、Ⅱ期、术前生物标志物试验:塞来昔布与依西美坦治疗绝经后乳腺癌患者的比较。
Cancer Prev Res (Phila). 2016 May;9(5):349-56. doi: 10.1158/1940-6207.CAPR-15-0311. Epub 2016 Feb 29.
8
Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: Evidence from real-life setting trials and surveys.口服非甾体抗炎药和镇痛药治疗骨关节炎的疗效与安全性:来自真实场景试验和调查的证据
Semin Arthritis Rheum. 2016 Feb;45(4 Suppl):S22-7. doi: 10.1016/j.semarthrit.2015.11.009. Epub 2015 Dec 2.
9
Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response.接受低剂量节拍化疗(环磷酰胺和塞来昔布)治疗的转移性乳腺癌患者:临床结局和反应的生物标志物。
Cancer Chemother Pharmacol. 2016 Feb;77(2):365-74. doi: 10.1007/s00280-015-2947-9. Epub 2015 Dec 31.
10
Efficacy and safety profile of celecoxib for treating advanced cancers: a meta-analysis of 11 randomized clinical trials.塞来昔布治疗晚期癌症的疗效和安全性概况:11项随机临床试验的荟萃分析
Clin Ther. 2014 Aug 1;36(8):1253-63. doi: 10.1016/j.clinthera.2014.06.015. Epub 2014 Jul 10.